|
Name |
Pycnophorin
|
Molecular Formula | C27H40O4 | |
IUPAC Name* |
3-[2-[(2R,4aS,5R,8aS)-2,4a-dimethyl-5-(4-methylpent-3-enyl)-6-oxo-3,4,5,7,8,8a-hexahydro-1H-naphthalen-2-yl]ethyl]-4-hydroxy-5,6-dimethylpyran-2-one
|
|
SMILES |
CC1=C(OC(=O)C(=C1O)CC[C@]2(CC[C@]3([C@H](C2)CCC(=O)[C@@H]3CCC=C(C)C)C)C)C
|
|
InChI |
InChI=1S/C27H40O4/c1-17(2)8-7-9-22-23(28)11-10-20-16-26(5,14-15-27(20,22)6)13-12-21-24(29)18(3)19(4)31-25(21)30/h8,20,22,29H,7,9-16H2,1-6H3/t20-,22-,26-,27-/m0/s1
|
|
InChIKey |
FPYZZNAGOQEQIN-LQMNMMRTSA-N
|
|
Synonyms |
Pycnophorin; DTXSID101318314; HY-N10278; CS-0373472; 103630-05-3
|
|
CAS | 103630-05-3 | |
PubChem CID | 139588482 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 428.6 | ALogp: | 6.4 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 63.6 | Aromatic Rings: | 3 |
Heavy Atoms: | 31 | QED Weighted: | 0.532 |
Caco-2 Permeability: | -4.672 | MDCK Permeability: | 0.00001880 |
Pgp-inhibitor: | 0.883 | Pgp-substrate: | 0.009 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.84 |
30% Bioavailability (F30%): | 0.891 |
Blood-Brain-Barrier Penetration (BBB): | 0.392 | Plasma Protein Binding (PPB): | 97.73% |
Volume Distribution (VD): | 3.147 | Fu: | 2.79% |
CYP1A2-inhibitor: | 0.133 | CYP1A2-substrate: | 0.608 |
CYP2C19-inhibitor: | 0.206 | CYP2C19-substrate: | 0.866 |
CYP2C9-inhibitor: | 0.405 | CYP2C9-substrate: | 0.896 |
CYP2D6-inhibitor: | 0.065 | CYP2D6-substrate: | 0.701 |
CYP3A4-inhibitor: | 0.69 | CYP3A4-substrate: | 0.18 |
Clearance (CL): | 7.504 | Half-life (T1/2): | 0.139 |
hERG Blockers: | 0.04 | Human Hepatotoxicity (H-HT): | 0.891 |
Drug-inuced Liver Injury (DILI): | 0.426 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.579 | Maximum Recommended Daily Dose: | 0.134 |
Skin Sensitization: | 0.487 | Carcinogencity: | 0.14 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.013 |
Respiratory Toxicity: | 0.797 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002960 | 0.331 | D0X7XG | 0.253 | ||||
ENC002301 | 0.313 | D03VFL | 0.237 | ||||
ENC005152 | 0.299 | D04GJN | 0.236 | ||||
ENC003782 | 0.288 | D04FBR | 0.230 | ||||
ENC002750 | 0.287 | D0W2EK | 0.228 | ||||
ENC001604 | 0.287 | D04VIS | 0.226 | ||||
ENC003420 | 0.286 | D04SFH | 0.226 | ||||
ENC003214 | 0.283 | D0X4RS | 0.226 | ||||
ENC002168 | 0.283 | D0L7AS | 0.225 | ||||
ENC003698 | 0.282 | D0G8BV | 0.223 |